- Home
- About the Audit
-
Resources
- Policies
- Guides
- Methodology
- Publications:
- NOD publications
- Annual Reports
- Posters
- Contributing centres:
- Centre Map
- Funding
- NOD Workshop
- NOD Workshop Feedback
- Patient Information
- Search Database
- News
The National Cataract Audit is currently funded through participation fees from centres as well as financial contributions from Alcon and Bausch + Lomb.
The Age-Related Macular Degeneration (AMD) Audit is currently kindly funded by the Macular Society, Novartis, Roche and Bayer. The project has been supported by an unrestricted, hands-off grant provided by Bayer plc. Bayer has had no involvement in the development, implementation or outputs of the project.
The following organisations have provided funding for the NOD Audit project:
We are grateful for the funding received from Alcon for the National Cataract Audit.
We are grateful for the funding received from Bausch + Lomb for the National Cataract Audit.
We are grateful for the funding received from the Macular Society for the National AMD Audit.
We are grateful for the funding received from Novartis for the National AMD Audit.